By Kiran Mazumdar-Shaw “A ship in port is safe, but that's not what ships are built for,” said Grace Hopper (1906–1992), one of the first programmers in the history of computers. Her belief that programming languages should be as easily understood as English was highly influential on the development of COBOL, one of the first computer … Continue reading We Need More Indian Women to Make a Mark in Science
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon It was very encouraging to see such a pragmatic, growth-focused budget that addresses the key need to boost economic recovery in the aftermath of the COVID-19 impact. This has been reflected in the market cheer following the announcement. The budget covers the major segments which needed redressal with big … Continue reading A Reassuring Budget Focused on Growth, Investment & Jobs
By Kiran Mazumdar-Shaw Chairperson, Biocon Group and member of The Lancet Citizen’s Commission on Re-imagining India’s Health System Technology can enable India to leapfrog into an advanced healthcare system that fulfils the vision of the national health policy of promoting wellness, universal access and affordable care for all Indians. The National Digital Health Mission (NDHM) … Continue reading Budget Push can Transform ASHA Workers from Health Activists to Digital Health Agents to deliver on NDHM
By Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics India’s healthcare standards have significantly improved over the past decades. Life expectancy has doubled from 35 years in 1950 to 70 years today. Most infectious diseases have been brought under control. Many key indicators of rural healthcare have also improved: Infant Mortality Rate (IMR) has reduced … Continue reading Economic Liberalisation and the Changing Face of Healthcare in India
India’s health regulator Drugs Controller General of India (DCGI) has granted Emergency Use Authorization (EUA) to two vaccines, Covaxin andCovishield , to fight the COVID-19 pandemic. Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR) and National Institute of Virology (NIV). Covishield has been developed by Oxford … Continue reading Indian regulator has granted Emergency Approval to Covaxin, Covishield based on strong scientific judgment.
India's health regulator Drugs Controller General of India (DCGI) has granted permission to two vaccines, Covishield and Covaxin, for "restricted use" in an emergency situation to fight the COVID-19 pandemic. Covishield has been developed by Oxford University scientists in collaboration with pharmaceutical company AstraZeneca. In India, its trial was undertaken by the Serum Institute of … Continue reading India needs to inoculate a million people a day against COVID-19
By Kiran Mazumdar Shaw, Executive Chairperson, Biocon As 2020 draws to a close amid news of a second wave of COVID-19 cases and the emergence of a mutant strain of the novel coronavirus in many parts of the world, there is hope yet that 2021 will be a better year for humanity. Some silver linings … Continue reading 2021: A New Year of Hope!
The Asian Scientist 100 is an annual listing of Asia's leading Scientists by the prestigious Asian Scientist Magazine. 2020 marks the 5th year of the launch of this list since 2016. Every year since 2016, Asian Scientist Magazine compiles a list of Asia’s most outstanding researchers. In the 2020 report, Asian Scientist Magazine has examined … Continue reading Kiran Mazumdar-Shaw recognized as the First Lady of Biotech by Asian Scientist Magazine
The COVID-19 pandemic has brought in its wake a tsunami of mental health concerns. A bad situation has been made worse by the limited healthcare resources available for people with mental illnesses as the entire focus is on containing the coronavirus situation. Children and older people, frontline health workers, people with existing mental health issues … Continue reading We must step up philanthropy for mental health: Kiran Mazumdar-Shaw
India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to Ms. Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd. With pooled testing that can include as many as 10 people in one … Continue reading India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says